Health and Life Sciences news
‘Purdue Innovates’ launches one united IP commercialization and startup creation network
To amplify the impact made by its faculty, staff, students and alumni, the Purdue Research Foundation and Purdue University have formed Purdue Innovates, a comprehensive system to streamline access to both (a) technology commercialization resources, such as intellectual property licensing and protection, and (b) startup support resources, including programs to launch, scale and invest in Purdue-connected startups in one cohesive structure.
Lack of canine COVID-19 data fuels persisting concerns over dog-human interactions
Early COVID-19 pandemic suspicions about dogs’ resistance to the disease have given way to a long-haul clinical data gap as new variants of the virus have emerged.
National Institutes of Health grant funds interdisciplinary stem cell research
A team of Purdue University scientists led by Shihuan Kuang has received a $2.5 million grant from the National Institutes of Health to define the role of lipid droplets in muscle stem cell function, a study with implications in both humans and livestock.
New high-tech startup developing smart contact lenses for glaucoma diagnosis and management
Optometrists, ophthalmologists and their patients will benefit from new, high-tech tools to detect glaucoma at its earliest stages thanks to a startup that will commercialize smart contact lenses developed at Purdue University.
Improving prostate cancer relapse forecast by 14 months
A new tool could help save lives by predicting prostate cancer relapse 14 months earlier than current standard methods. The tool, a computer model, makes its predictions by using levels of a single biomarker produced by prostate cells to forecast the interplay of biochemical reactions linked to prostate cancer.
Imaging agent illuminates lung cancer tumors
Surgery, especially surgery to remove cancerous tumors, relies on a range of tools and techniques as well as on the skill of the surgeon. Now, new imaging agent Cytalux will make surgery to remove lung cancer tumors a little more exact.
Comparative oncology research center at Purdue to be named for Evan and Sue Ann Werling
The Purdue University Board of Trustees has approved the naming of the Evan and Sue Ann Werling Comparative Oncology Research Center in recognition of the donors’ $10 million gift. The center, part of the College of Veterinary Medicine, will partner with the Purdue Center for Cancer Research (PCCR) to advance cancer research benefiting pets and humans.
